53562-86-0,
Methyl (S)-(+)-3-hydroxybutyrate,
(S)-methyl 3-hydroxybutanoate,
Methyl (S)-3-hydroxybutyrate,
(S)-3-HYDROXYBUTANOIC ACID METHYL ESTER,
UNII-G10281A5AH,
methyl (3S)-3-hydroxybutanoate,
(S)-(+)-3-Hydroxy-N-butyric acid methyl ester,
Butanoic acid, 3-hydroxy-, methyl ester, (3S)-,
(S)-(+)-3-Hydroxybutyric Acid Methyl Ester,
LDLDJEAVRNAEBW-BYPYZUCNSA-N,
G10281A5AH,
MFCD00064461,
(S)-3-hydroxybutyric acid methyl ester,
Methyl (S)-(+)-3-hydroxybutyrate, 99%,
Methyl 3-hydroxybutyrate, (+)-,
EINECS 258-628-8,
AC1OCTCH,
PubChem13965,
Butanoic acid, 3-hydroxy-, methyl ester, (S)-,
AC1Q41UF,
SCHEMBL55045,
KSC598G8F,
methyl-(s)-3-hydroxybutyrate,
CTK4J8382,
KS-00000GJU,
(S)-3-Hydroxybutyric acid methyl,
ZINC388770,
Methyl(S)-(+)-3-hydroxybutyrate,
EBD22091,
(+)-Methyl (S)-3-hydroxybutyrate,
(s)-(+)-methyl-3-hydroxybutanoate,
Methyl (S)-(-)-3-hydroxybutyrate,
ANW-31798,
RW2735,
Methyl-(S)-(+)-3-hydroxy butryate,
AKOS015855397,
CS-W013601,
LS30199,
NE11132,
AC-25566,
AJ-20773,
AS-13349,
BC228164,
BP-10858,
CJ-03345,
H966,
H996,
SC-08903,
ZB011700,
AB0013390,
DB-009765,
ST2402873,
TR-018949,
AM20090811,
FT-0628827,
(+)-(3S)-3-Hydroxybutanoic acid methyl ester,
Butanoic acid,3-hydroxy-, methyl ester, (3S)-,
562M860,
W-111735,
UNII-S36O46U3EA component LDLDJEAVRNAEBW-BYPYZUCNSA-N,
(+)-Methyl (S)-3-hydroxybutyrate, puriss., >=99.0% (sum of enantiomers, GC),
Eprazinone 2HCl,
Methyl 3-hydroxybutyrate,
methyl(s)-3-hydroxybutyrate,
C24H34Cl2N2O2,
C5H10O3,
C5-H10-O3,
ACN-035906,
CB10007,
CB11700,
CID6950307,
(4-Bromophenyl)methanesulphonyl chloride,
H0704,
Methyl (S)-(+)-3-hydroxybutyrate, 98% 1g,
Methyl (S)-( )-3-hydroxybutyrate, 98% - 1G 1g,
10402-53-6,